Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 17.

FDA-approved drug restores hair in patients with alopecia areata
Researchers have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 18, 2014 Category: Science Source Type: news

Bone marrow drug could treat alopecia
Conclusion This is valuable laboratory research that identifies the specific type of immune cell (CD8+NKG2D+ T cells) that is involved in the disease process of alopecia. It further identifies several signalling molecules that are drivers of this T cell activity. The researchers then demonstrate that giving two molecular treatments to block the signalling molecules – ruxolitinib (currently licensed in the UK to treat certain bone marrow disorders) and tofacitinib (not currently licensed for any condition in the UK) – were effective in preventing and reversing the disease process in mice with alopecia. These findings i...
Source: NHS News Feed - August 18, 2014 Category: Consumer Health News Tags: Medication Source Type: news

New Drug Helps Some Bald Patients Regrow Hair
The drug, which suppresses immune system activity, showed significant results for several sufferers of the autoimmune disease alopecia areata. (Source: NYT Health)
Source: NYT Health - August 17, 2014 Category: Consumer Health News Authors: By PAM BELLUCK Tags: Hair Arthritis Research Nature Medicine (Journal) Columbia University Medical Center Raphael Clynes Bristol Myers Squibb Company BMY NYSE Alopecia Areata Christiano, Angela Immune System Source Type: news

FDA-approved drug restores hair in patients with Alopecia Areata
(Columbia University Medical Center) Researchers at Columbia University Medical Center have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.The results appear in today's online issue of Nature Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2014 Category: Global & Universal Source Type: news

Genetic signal prevents immune cells from turning against the body
(Salk Institute) Salk scientists find a control signal for the immune system that could help treat autoimmune diseases and cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 14, 2014 Category: Biology Source Type: news

National Psoriasis Foundation on Improving the Lives of Patients
Millions of Americans with psoriatic arthritis—a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated—struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change with the largest realignment and expansion of its psoriatic arthritis program. For nearly two decades, the Psoriasis Foundation has provided disease-management services and information to people with psoriatic arthritis (PsA), which affects as many as one in three people with psoriasis, the most common autoimmune...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Npf
PartnerThe National Psoriasis Foundation (NPF) is a non-profit, voluntary health agency dedicated to finding a cure for psoriasis and psoriatic arthritis and eliminating their devastating effects through research, advocacy and education.  Founded in 1968, the Psoriasis Foundation has evolved to become the leading patient advocacy group for the 7.5 million Americans living with psoriasis and psoriatic arthritis.  As emerging research continues to demonstrate the serious, systemic effects of these chronic autoimmune diseases, our highest priority is to find a cure. NPFNational.Psoriasis.FoundationCompany: Arthritis Co...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Gene that controls nerve conduction velocity linked to multiple sclerosis
A novel gene that controls nerve conduction velocity has been identified in a new study. Investigators report that even minor reductions in conduction velocity may aggravate disease in multiple sclerosis (MS) patients and in mice bred for the MS-like condition experimental autoimmune encephalomyelitis (EAE). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 13, 2014 Category: Science Source Type: news

Gene that controls nerve conduction velocity linked to multiple sclerosis
(Elsevier Health Sciences) A new study published in The American Journal of Pathology identifies a novel gene that controls nerve conduction velocity. Investigators report that even minor reductions in conduction velocity may aggravate disease in multiple sclerosis patients and in mice bred for the multiple sclerosis-like condition experimental autoimmune encephalomyelitis. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 13, 2014 Category: Biology Source Type: news

'Worm pill' could ease autoimmune disease symptoms
Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. The study successfully identified peptides from parasitic worms that suppress the body's immune response. Researchers believe this could pave the way for a new drug containing the peptide to provide relief from the symptoms of autoimmune diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2014 Category: Science Source Type: news

Is the gut microbiome a potential cause and therapeutic target for autoimmune diseases like multiple sclerosis?
(Mary Ann Liebert, Inc./Genetic Engineering News) Numerous risk factors are believed to contribute to the development of autoimmune disorders such as multiple sclerosis, and new research is focusing on the role that bacteria in the gastrointestinal tract as well as other cell stress-related chemical signals could have in stimulating inflammation in the central nervous system and activating immunostimulatory cytokines. Two comprehensive Review articles are part of a focus on 'Cytokines in Neuroinflammation and Immunity' in a special issue of Journal of Interferon & Cytokine Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2014 Category: Global & Universal Source Type: news

Gabriela Lavezzari on Improving the Lives of Patients with Arthritis
Many people are unaware of the impact of arthritis and related musculoskeletal diseases in the United States. They affect approximately 52.5 million Americans of all ages, races and genders. The biopharmaceutical industry is making great strides towards new treatments with 92 medicines in the pipeline which have the potential to help patients live more active and productive lives. Work on these treatments is more imperative than ever as 67 million people could be diagnosed with some form of musculoskeletal disease by 2030, according to the U.S. Centers for Disease Control and Prevention. Earlier this year, PhRMA joined 10...
Source: PHRMA - August 4, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Warning over waistline link to type 2 diabetes
“Belly fat clearest sign of type 2 diabetes risk,” The Guardian reports. This comes as Public Health England publishes a report highlighting the links between bulging waistlines, obesity and type 2 diabetes risk.According to a new report, men whose waist size is over 102cm (40.2 inches) are five times more likely to develop diabetes than those with a smaller waist size. Women with a waist over 88cm (34.7 inches) are three times more likely to develop the condition.The report says that being overweight or obese is the main avoidable risk factor for type 2 diabetes.The condition is now a major public health issue, with ...
Source: NHS News Feed - July 31, 2014 Category: Consumer Health News Tags: Diabetes Obesity QA articles Source Type: news

Stephen I. Katz on Improving the Lives of Patients with Arthritis
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials. NIAMS was a key contributor to the development of tofacitinib, the first oral disease modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA) in a decade, which recently received  approval from the U.S. Food and Drug Administration. In the early 1990’s, NIAMS intramural researchers discovered Janu...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Amanda Niskar on Improving the Lives of Patients with Arthritis
For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve health outcomes for people with arthritis. Research holds the key to finding better diagnostics and treatments—and one day a cure—for more than 50 million Americans who face the daily challenges of arthritis. At the Foundation, we are focused on providing scientific leadership and direction to improve everyday life for people with arthritis and to find a cure.   Information from the Medicines in Development report issued by the Pharmaceutical Research Manufacturers of America (PhRMA), about medicines that are ...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Asbestos Revisited: A New Autoimmune Disease? (CME/CE)
(MedPage Today) -- In the small town of Libby in northwestern Montana, prospectors in 1916 discovered an unusual mineral known as vermiculite that appeared to be resistant to fire after initial exposure to high heat. But the vermiculite was contaminated with asbestos, which killed many residents and now may be contributing to high rates of autoimmunity. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 29, 2014 Category: Primary Care Source Type: news

Mysterious esophagus disease is autoimmune after all
(KU Leuven) Achalasia is a rare disease -- it affects one in 100,000 people -- characterized by a loss of nerve cells in the esophageal wall. While its cause remains unknown, a new study by a team of researchers at KU Leuven in Belgium, the University of Bonn in Germany and other European institutions confirms for the first time that achalasia is autoimmune in origin. The study, published on July 6 in Nature Genetics, is an important step towards unraveling the mysterious disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 29, 2014 Category: Biology Source Type: news

Study links shift work to increased risk of diabetes
Conclusion This systematic review finds an association between shift work and diabetes, overall the pooled results found that shift work was associated with a 9% risk of diabetes. The review has strengths in that it has reviewed the global literature and identified a reasonable sample of 12 observational studies including more than 225,000 people. However, there are various important limitations that need to be taken into account before concluding that shift work directly increases the risk of diabetes. Type 1 or type 2? The main point under investigation was whether shift work could be a modifiable risk factor for the de...
Source: NHS News Feed - July 25, 2014 Category: Consumer Health News Tags: Diabetes Lifestyle/exercise Source Type: news

Biomedical engineer looks at new applications for novel lupus drug
(University of Houston) Expanding on his work with a new drug that successfully treated lupus in mice, a biomedical engineer at the University of Houston has received a $250,000 grant to expand his research to a new version of the drug in an effort to treat a wider range of autoimmune diseases.The drug that Chandra Mohan and his collaborators at a biopharmaceutical firm are focused on targets B cells, key cells in the immune system that lead to the development of lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2014 Category: Global & Universal Source Type: news

Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed
(Helmholtz Zentrum München - German Research Center for Environmental Health) Neuherberg, 14 July 2014. Scientists at the Helmholtz Zentrum München, the Ludwig-Maximilians University of Munich and the Technische Universität München have moved an important step closer to understanding molecular mechanisms of autoimmune diseases. They solved the three-dimensional structure of the Roquin protein when bound to messenger ribonucleic acid molecules. The results revealed that there is a much wider range of functionally important Roquin binding partners than previously assumed. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 14, 2014 Category: Biology Source Type: news

Immune/Inflammatory Response and Autism
Autism Spectrum Disorder (ASD) Children and Immune/Inflammatory Response MarkersPersistent chronic inflammation/immune response and oxidative stress are hallmarks of ASD. Like autoimmune diseases, an unbalanced immune system leads to unwanted assaults on healthy tissue. In ASD Children, inflammatory/immune response proteins could cross the Blood-Brain Barrier resulting in ongoing neuro-inflammation. This throws out of balance the natural pruning and repair cycle in the brain and could drive the related behaviors and symptoms of ASD Children.We have been working with ASD children from central Europe residing in areas of hea...
Source: Neuromics - July 11, 2014 Category: Neuroscience Tags: ASD Autism Autism Bio-markers autism spectrum disorder Autistic Autoimmunity IL-2 immune response IL-6 inflammatory response TNF-alpha Source Type: news

Research reveals how key controller protein is switched on
(Biochemical Society) New research has uncovered how a complex protein pivotal in the development of cancer, viral infection and autoimmune diseases is activated. The discovery answers a key question about one of the most widely-researched proteins in human biology, which has been the subject of tens of thousands of research papers and millions of pounds in research funding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2014 Category: Global & Universal Source Type: news

Periodontal Disease in Rheumatoid ArthritisPeriodontal Disease in Rheumatoid Arthritis
A study finding that periodontal disease is associated with RA considers the interesting question of whether the periodontal region, like the joints, are targeted by the autoimmune process. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 9, 2014 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news

Immune system component found that resists sepsis in mice
Mice lacking a specific component of the immune system are completely resistant to sepsis, a potentially fatal complication of infection, molecular microbiologists report. The discovery suggests that blocking this immune system component may help reduce inflammation in human autoimmune and hyper-inflammatory diseases such as rheumatoid arthritis and Type 2 diabetes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 9, 2014 Category: Science Source Type: news

Glenmark begins human trials of GBR 830 to treat autoimmune diseases
Glenmark Pharmaceuticals' Swiss subsidiary has announced that its new monoclonal antibody GBR 830 is entering human trials for the treatment of autoimmune diseases. (Source: Drug Development Technology)
Source: Drug Development Technology - July 3, 2014 Category: Pharmaceuticals Source Type: news

Genetics Home Reference: autoimmune Addison disease
http://ghr.nlm.nih.gov/condition/autoimmune-addison-disease (Source: NLM General Announcements)
Source: NLM General Announcements - July 1, 2014 Category: Databases & Libraries Source Type: news

Soothing cells, peaceful protein could hold promise for treating autoimmune uveitis
Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss. (Source: News from NEI)
Source: News from NEI - June 30, 2014 Category: Opthalmology Source Type: news

Xtalks Announces Its July 2014 Webinars
Join Xtalks for this month’s calendar of free webinars, which features insightful discussions about risk-based monitoring (RBM), inflammatory bowel disease, sepsis, autoimmune diseases, biopharma,...(PRWeb June 27, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11966854.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 27, 2014 Category: Pharmaceuticals Source Type: news

Depressed? It May Be Celiac Disease
Melanie had been feeling out of sorts for years. No matter how well she slept, she was often fatigued. She had frequent headaches. She had diarrhea so often, she figured it was just how her body worked. She wryly said that she knew where every bathroom in town was located. Although an upbeat person by nature, it was hard for her to be happy when she felt bad so often. Nonetheless, some days were better than others. She was determined not to let how she felt physically get her down. Mel had been going to doctors for years to try to get an answer. Diagnoses included irritable bowel syndrome (IBS), migraine, lactose intoleran...
Source: Psych Central - June 21, 2014 Category: Psychiatry Authors: Marie Hartwell-Walker, Ed.D. Tags: Depression Disorders General Healthy Living Celiac Disease Gluten Gluten-free diet Irritable bowel syndrome National Foundation for Celiac Awareness Source Type: news

T1D Gene May Play Role in Other Diseases (CME/CE)
(MedPage Today) -- New insights into the function of a type 1 diabetes susceptibility gene could lead to novel strategies for treating a host of autoimmune diseases, according to researchers. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 20, 2014 Category: Cardiology Source Type: news

Pig whipworm genome may aid to treat autoimmune diseases
The whole-genome sequence of Trichuris suis, a parasitic worm in pig, has been presented by an international team composed of 11 institutions from six countries. Understanding the genetics mechanisms underlying the pig parasite may aid to modify the human immune response that could result in better treatments for autoimmune diseases, including inflammatory bowel disease and multiple sclerosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 20, 2014 Category: Science Source Type: news

The pig whipworm genome may aid to treat autoimmune diseases
(BGI Shenzhen) An international team, composed of 11 institutions from six countries, including BGI, presented the whole-genome sequence of Trichuris suis, a parasitic worm in pig. Understanding the genetics mechanisms underlying the pig parasite may aid to modify the human immune response that could result in better treatments for autoimmune diseases, including inflammatory bowel disease and multiple sclerosis. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 20, 2014 Category: Biology Source Type: news

Teen's struggle with 'old person's' disease: 'I had rheumatoid arthritis at 16'
DISTRESSED Heather Edwards was struggling to walk, kneel down or extend her elbows when she was diagnosed with the autoimmune disease - aged just 16 (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2014 Category: Consumer Health News Source Type: news

New method to reduce disease-causing inflammation discovered
An enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system, researchers report. Their discovery may one day lead to new treatments for many common autoimmune diseases. "This is an emerging field," one researcher said. "We have a lot of work to do, but many of our preliminary results are promising." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 16, 2014 Category: Science Source Type: news

UGA researchers discover new method to reduce disease-causing inflammation
(University of Georgia) Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system. Their discovery may one day lead to new treatments for many common autoimmune diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2014 Category: Global & Universal Source Type: news

Neuromics-Vitro Biopharma in Posrche Cup
Racing to Health and Peak Performance.Neuromics and Vitro Biopharma are proud sponsors of the European Porsche Cup Car driven by our partner, friend and race car driver extraordinaire, Dr. Joe Smarda.Dr. Smarda, an applied immunologist, is our partner in Europe for testing and treating sufferers of autoimmune diseases, sports injuries and autism with Stem Cell Activators. We are also testing these activating agents for the ability to improve the mental acuity and physical performance of healthy individuals.He recently won a race at the Nurbring Ring in Germany. Hmmm, I wonder if the Stem Cell Activators he is taking, ...
Source: Neuromics - June 15, 2014 Category: Neuroscience Tags: Neuromics Porsche Cup Racing regenerative medicine sports medicine stem cell activation stem cell activators Stem Cell Based Therapies Vitro Biopharma Source Type: news

Parasitic worms of pigs could provide new treatments of human diseases
(University of Melbourne) Lead researcher, Dr. Aaron Jex, Faculty of Veterinary Science, said, 'We know that humans infected with the harmless, 'pig whipworm' can have significantly reduced symptoms linked to autoimmune diseases. And now we have the genetic sequence of the worm, it opens the door to future human drug designs and treatment.' (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2014 Category: Infectious Diseases Source Type: news

Invisible Illness: It’s not easy to combat what you can’t see!
There is a surprising common factor which is shared by a vast range of physical and mental health conditions. Fibromyalgia, anxiety, endometriosis, lupus, endometriosis, pelvic pain and depression may vary in causes and symptoms, but all of them have a deadly weapon in common – invisibility. They are often classed as an invisible illness. These conditions fight their invisible war on two fronts. Firstly, they leave no trace. The majority of these diseases attack the body internally, leaving no external signs which might allow the patient’s suffering to be easily recognised. As well as causing physical pain, invisible i...
Source: The Hysterectomy Association - June 13, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health Conditions anxiety autoimmune disease depression endometriosis fibromyalgia invisible illness lupus pelvic pain Source Type: news

Evaluation of the Adverse Effect of Low Concentration of Cadmium on Interleukin-4 Induced Class Switch Recombination in Burkett’s Lymphoma Raji Cell Line
Affinity maturation of B lymphocytes, a process that includes somatic hypermutation and class switch recombination, initiates global DNA rearrangements. The interruption of this process has an adverse effect on human health and results in immunodeficiency and autoimmune disease. Class switch recombination is a fundamental factor of the human adaptive immunity. Evaluation of the class switch recombination efficiency is an important component of laboratory diagnostic of immunotoxic components. Here, we describe a method for testing the efficiency of the class switch recombination. Cultivation of Raji Burkett’s lymphoma...
Source: Springer protocols feed by Immunology - June 10, 2014 Category: Allergy & Immunology Source Type: news

Chemotactic Responses by Macrophages to a Directional Source of a Cytokine Delivered by a Micropipette
Macrophages, which are organized throughout every tissue, represent a key component of the immune system and the recruitment of macrophages to specific sites is important in normal host defense. However, when inappropriately recruited macrophages may damage or destroy healthy tissue; this is seen in several autoimmune diseases such as arthritis. Many cytokines, including CSF-1 and chemokines, are often upregulated in inflamed tissues and can induce the directional migration of macrophages towards the highest concentration of the cytokine in a process called chemotaxis. Chemokines were first described as chemoattractant cyt...
Source: Springer protocols feed by Immunology - June 10, 2014 Category: Allergy & Immunology Source Type: news

Faster, higher, stronger: A protein that enables powerful initial immune response
(The Wistar Institute) A team of Wistar scientists offer evidence that a protein, called Foxp1, is a key controller of our immune system's ability to generate an antibody response. Manipulating this protein's activity, they say, could provide a useful pathway to boosting antibody responses to treat infectious diseases, for example, or suppressing them to treat autoimmune disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2014 Category: Global & Universal Source Type: news

Stem Cell Therapies without Transplants
Neuromics is partnering with Vitro Biopharma to develop stem cell activating/boosting therapies. Stem cell based therapies represent a shining light of hope for sufferers of chronic or life threatening diseases.  Though, for most, realization of this hope is light years into the future.Dr. Jim Musick, CEO of Vitrobiopharma, recently blogged on the obstacles to approved therapies : "Transplantation of hematopoietic stem cells has been widely used as an approved treatment of leukemia, lymphoma and certain autoimmune conditions for the past fifty years. Other adult stem cells have demonstrated safety and effica...
Source: Neuromics - June 7, 2014 Category: Neuroscience Tags: hMCS Human Mesenchymal Stem Cells regenerative medicine stem cell activation stem cell activators stem cell boosters stem cell therapies Source Type: news

Autoimmune Disease & Risk of Gastric Neuroendocrine NeoplasmAutoimmune Disease & Risk of Gastric Neuroendocrine Neoplasm
Are patients with thyroid disease at risk for gastric neuroendocrine neoplasms? Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 5, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Arena begins Phase Ib trial of APD334 to treat autoimmune diseases
US-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor, to treat a number of autoimmune diseases. (Source: Drug Development Technology)
Source: Drug Development Technology - June 4, 2014 Category: Pharmaceuticals Source Type: news

Marijuana shows potential in treating autoimmune disease
Researchers have discovered a novel pathway through which marijuana's main active constituent, THC, can suppress the body's immune functions. The recent findings show that THC can change critical molecules of epigenome called histones, leading to suppression of inflammation. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 2, 2014 Category: Science Source Type: news

Marijuana shows potential in treating autoimmune disease
(University of South Carolina) A team of University of South Carolina researchers have discovered a novel pathway through which marijuana can suppress the body's immune functions. The recent findings show that marijuana THC can change critical molecules of epigenome called histones, leading to suppression of inflammation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 2, 2014 Category: Global & Universal Source Type: news

A Product For Gaucher Disease And A Plant-Cell For Protein Production – Protalix Biotherapeutics Is On The Rise
Protalix has a unique plant-cell platform for therapeutic protein production and an approved product, Elelyso/Uplyso (taliglucerase alfa), for Gaucher disease. In the company’s pipeline is a chemically modified version of the recombinant alpha-Galactosidase-A protein for Fabry disease (Phase 1/2), an oral glucocerebrosidase (GCD) enzyme replacement therapy for Gaucher disease (Phase 1), an oral anti-TNF (tumor necrosis factor) fusion protein for autoimmune/inflammatory conditions (preclinical), and a human deoxyribonuclease I (DNase I) for cystic fibrosis (preclinical), and other enzyme replacement therapies in early...
Source: Pharmaceutical Online News - May 30, 2014 Category: Pharmaceuticals Source Type: news

FDA allows marketing of first non-invasive test to help in identifying cause of certain kidney disease
Today, the U.S. Food and Drug Administration allowed marketing of the first test that can help determine if a specific type of kidney disease, called membranous glomerulonephritis (MGN), is due to the body’s rejection of its own kidney tissue (autoimmune) or if it is due to another cause (such an infection). (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 29, 2014 Category: American Health Source Type: news

IgG Stable With Rituxan in Autoimmune Disease
(MedPage Today) -- Repeated doses of rituximab in patients with vasculitis or lupus had no association with increased rates of low immunoglobulin (Ig)G, an important infection-fighting component of the immune system, a retrospective study found. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 28, 2014 Category: Infectious Diseases Source Type: news

Lupus Therapies Continue to Evolve
May is National Lupus Awareness Month, a time to think about lupus and the challenges it presents to patients. Learn about this chronic, autoimmune disease and the promise of future therapies. (Source: FDA Consumer Updates)
Source: FDA Consumer Updates - May 27, 2014 Category: Consumer Health News Source Type: news